Dr. Graeme Archer is VP & Head of the Non-clinical and Translational Statistics (NCTS) group in GSK R&D. NCTS ensures integrity in the design, analysis and interpretation of models and experiments developed by GSK’s Research Units – Graeme is particularly focused on ‘translation’ (what do we predict will be observed in man, and how confident in those predictions should we be?) On GSK’s Research governance boards he strives for statistical rigour in portfolio decision-making – and was joint winner of the 2019 Royal Statistical Society’s Pharmaceutical Excellence award for his work on Quantitative Decision-Making. His 1990s PhD, from the University of Glasgow, concerned Bayesian methods for image analysis – early ‘machine learning’? – and as a consequence he is a champion for synergy between the statistical and AI/ML communities. Graeme spent a sabbatical year in 2016 as a speech-writer for a British cabinet minister.
- Amy P. Abernethy, US FDA
- Graeme Archer, GSK R&D
- Jesse Berlin, Johnson & Johnson
- Lawrence Carin, Duke
- Noémie Elhadad, Columbia
- Igor Jurisica, Krembil Research Institute and University of Toronto
- Faisal Khan, AstraZeneca
- Kannan Natarajan, Pfizer
- Amol Navathe, University of Pennsylvania
- Adler Perotte, Columbia
- Patrick Ryan, Janssen Research and Development
- Mary Ann Slack, US Food and Drug Administration (FDA)
- Simon Tavaré, Columbia
- Mihaela van der Schaar, Cambridge
- Li Wang, AbbVie
Countdown to AIPM
AIPM has begun!
Welcome Address — David Madigan, Ph.D., Columbia University
A Perspective on the Promise and Pitfalls of Artificial Intelligence in Clinical Drug Development — Kannan Natarajan, Pfizer Inc.
Machine Learning: Changing the future of healthcare – from next generation clinical trials to individualized treatment effects — Mihaela van der Schaar, University of Cambridge
Discussant — Patrick Ryan, Janssen Research and Development
ML and AI in Clinical Development and Statistical Innovation — Wang Li, AbbVie.
Opportunities for AI in Healthcare — Lawrence Carin, Duke University
- Demissie Alemayehu, Pfizer Inc.
- David Madigan, Columbia University